IntelGenx Enters Into Amended and Restated License Agreement with Tetra Bio-Pharma for Adversa® Mucoadhesive Delivery Technology for Dronabinol

SAINT LAURENT, Quebec, Oct. 21, 2020 (GLOBE NEWSWIRE) — IntelGenx Corp. (TSX-V:IGX)(OTCQB:IGXT) (the “Company” or “IntelGenx”) today announced that it has

Read more